Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,700 | 2 | 95.1% |
| Food and Beverage | $242.31 | 9 | 4.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $4,700 | 2 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $231.27 | 8 | $0 (2023) |
| Amgen Inc. | $11.04 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $40.00 | 1 | Novartis Pharmaceuticals Corporation ($40.00) |
| 2022 | $32.00 | 1 | Novartis Pharmaceuticals Corporation ($32.00) |
| 2021 | $27.66 | 1 | Novartis Pharmaceuticals Corporation ($27.66) |
| 2020 | $37.50 | 1 | Novartis Pharmaceuticals Corporation ($37.50) |
| 2019 | $20.11 | 1 | Novartis Pharmaceuticals Corporation ($20.11) |
| 2018 | $1,563 | 4 | PFIZER INC. ($1,500) |
| 2017 | $3,223 | 2 | PFIZER INC. ($3,200) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/29/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $40.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/30/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $32.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/11/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $27.66 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/29/2020 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $37.50 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/09/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/17/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $27.50 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/25/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/06/2018 | Amgen Inc. | Parsabiv (Biological) | Food and Beverage | In-kind items and services | $11.04 | General |
| Category: Nephrology | ||||||
| 02/01/2018 | PFIZER INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $1,500.00 | General |
| 11/06/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/31/2017 | PFIZER INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $3,200.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 114 | 303 | $713,597 | $48,355 |
| 2022 | 5 | 102 | 372 | $891,201 | $57,892 |
| 2021 | 6 | 130 | 428 | $977,757 | $70,062 |
| 2020 | 6 | 151 | 521 | $1.3M | $78,604 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 16 | 127 | $586,994 | $33,861 | 5.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 30 | 53 | $25,864 | $4,746 | 18.3% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2023 | 20 | 71 | $59,569 | $4,571 | 7.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 31 | 31 | $24,118 | $4,047 | 16.8% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 17 | 21 | $17,052 | $1,131 | 6.6% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 19 | 167 | $749,329 | $45,915 | 6.1% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 35 | 100 | $78,800 | $5,533 | 7.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 19 | 43 | $20,382 | $3,369 | 16.5% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2022 | 17 | 46 | $37,490 | $2,205 | 5.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 12 | 16 | $5,200 | $869.45 | 16.7% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 28 | 190 | $827,640 | $52,769 | 6.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 35 | 86 | $39,560 | $6,803 | 17.2% |
| 90945 | Dialysis procedure including one evaluation | Facility | 2021 | 23 | 87 | $68,817 | $5,801 | 8.4% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2021 | 22 | 37 | $28,305 | $2,086 | 7.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 11 | 11 | $8,063 | $1,686 | 20.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 11 | 17 | $5,372 | $916.39 | 17.1% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2020 | 32 | 272 | $1.2M | $60,911 | 5.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 32 | 78 | $34,866 | $6,336 | 18.2% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2020 | 41 | 95 | $70,585 | $5,357 | 7.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 19 | 49 | $15,043 | $2,859 | 19.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 13 | 13 | $9,256 | $2,054 | 22.2% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 14 | 14 | $6,076 | $1,087 | 17.9% |
About Dr. Samuel Blumenthal, MD
Dr. Samuel Blumenthal, MD is a Nephrology healthcare provider based in Milwaukee, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1437100880.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Samuel Blumenthal, MD has received a total of $4,942 in payments from pharmaceutical and medical device companies, with $40.00 received in 2023. These payments were reported across 11 transactions from 3 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($4,700).
As a Medicare-enrolled provider, Blumenthal has provided services to 497 Medicare beneficiaries, totaling 1,624 services with total Medicare billing of $254,913. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Location Milwaukee, WI
- Active Since 05/12/2006
- Last Updated 02/08/2013
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1437100880
Products in Payments
- ENTRESTO (Drug) $159.27
- LEQVIO (Drug) $72.00
- Parsabiv (Biological) $11.04
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Milwaukee
Dr. Kevin Regner, M.d, M.D
Nephrology — Payments: $154,906
Dr. Manohar Ahuja, M.d, M.D
Nephrology — Payments: $32,239
Anna Gaddy, M.d, M.D
Nephrology — Payments: $16,014
Dr. Ahmed Malik, M.d, M.D
Nephrology — Payments: $15,742
Dr. Kevin Tucker, Md, MD
Nephrology — Payments: $7,904
Dr. Brahm Vasudev, Md, MD
Nephrology — Payments: $7,102